{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:43:58Z","timestamp":1760852638189,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1999,10,1]],"date-time":"1999-10-01T00:00:00Z","timestamp":938736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1999,10,1]],"date-time":"1999-10-01T00:00:00Z","timestamp":938736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007688","name":"American University of Beirut","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[1999,10]]},"DOI":"10.1006\/gyno.1999.5519","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T18:50:18Z","timestamp":1032288618000},"page":"15-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Tamoxifen and Endometrial Pathologies: A Prospective Study"],"prefix":"10.1006","volume":"75","author":[{"given":"Muhieddine","family":"Seoud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Shamseddine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziad","family":"Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagi","family":"Saghir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal","family":"Bikhazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nizar","family":"Bitar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghassan","family":"Azar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Kaspar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.1999.5519_RF1","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/jnci\/88.21.1529","article-title":"Tamoxifen and chemotherapy for lymph node negative, estrogen receptor positive breast cancer","volume":"88","author":"Fisher","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1006\/gyno.1999.5519_RF2","unstructured":"Wickerman, D, L, Constantino, J, C, Fisher, B, Kavanah, M, Cronin, W, Vogel, V, Robidoux, A, Daly, M, Ford, L, Redmond, C, K, Wolmark, N, The initial results from NSABP protocol P-1: a clinical trial to determine the worth of tamoxifen for preventing breast cancer in women at increased risk. Proc Am Soc Clin Oncol, plenary session 3A, 1998, [Abstract]"},{"key":"10.1006\/gyno.1999.5519_RF3","first-page":"237","article-title":"Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens","volume":"69","author":"Killackey","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"10.1006\/gyno.1999.5519_RF4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0020-7292(95)02387-R","article-title":"Gynecological effect of tamoxifen and the association with endometrial cancer","volume":"49","author":"Assikis","year":"1995","journal-title":"Int J Gynecol Obstet"},{"key":"10.1006\/gyno.1999.5519_RF5","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/0959-8049(96)00184-0","article-title":"A realistic clinical perspective of tamoxifen and endometrial carcinogenesis","volume":"32A","author":"Assikis","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1006\/gyno.1999.5519_RF6","first-page":"165","article-title":"Gynecologic tumors in tamoxifen-treated women with breast cancer","volume":"82","author":"Seoud","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.1999.5519_RF7","first-page":"660","article-title":"Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen","volume":"81","author":"Lathi","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.1999.5519_RF8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0090-8258(91)90330-8","article-title":"Oncologic potential of tamoxifen on endometria of postmenopausal women with breast cancer: preliminary report","volume":"42","author":"Gal","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.1999.5519_RF9","first-page":"863","article-title":"Endometrial pathology at dilatation and curettage in breast cancer patients: comparison of tamoxifen users and nonusers","author":"Gibson","year":"1994","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1006\/gyno.1999.5519_RF10","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/S0140-6736(94)92466-X","article-title":"Effects of tamoxifen on uterus and ovaries of post menopausal women in a randomized cancer prevention trial","volume":"343","author":"Kedar","year":"1994","journal-title":"Lancet"},{"key":"10.1006\/gyno.1999.5519_RF11","first-page":"779","article-title":"The effect of adjuvant tamoxifen on the endometrium in women with breast cancer: an interim analysis of a prospective study","author":"Barakat","year":"1995","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1006\/gyno.1999.5519_RF12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/bjc.1987.16","article-title":"On the age-dependent association between cancer of the breast and endometrium. A nationwide cohort study","volume":"55","author":"Adami","year":"1987","journal-title":"Br J Cancer"},{"key":"10.1006\/gyno.1999.5519_RF13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jnci\/86.7.527","article-title":"Endometrial cancer in tamoxifen treated breast cancer patients","volume":"86","author":"Fisher","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1006\/gyno.1999.5519_RF14","first-page":"812","article-title":"Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse","volume":"48","author":"Gourtadis","year":"1988","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.1999.5519_RF15","first-page":"1045","article-title":"Endometrial carcinoma in breast cancer patients treated with tamoxifen: activation of the K-ras proto-oncogene","volume":"4","author":"Varras","year":"1997","journal-title":"Oncol Rep"},{"key":"10.1006\/gyno.1999.5519_RF16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1006\/gyno.1997.4831","article-title":"Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies","volume":"67","author":"Cohen","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.1999.5519_RF17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0029-7844(97)00549-8","article-title":"The effects of tamoxifen on endometrial insulin-like growth factor-1 expression","volume":"91","author":"Elkas","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.1999.5519_RF18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.1993.11.3.485","article-title":"High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients","volume":"11","author":"Magriples","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.1999.5519_RF19","unstructured":"National Cancer Institute, SEER cancer statistics review 1973\u20131990, document 93-2789, Bethesda, MD, National Cancer Institute, 1993"},{"key":"10.1006\/gyno.1999.5519_RF20","first-page":"171","volume":"ii","year":"1987","journal-title":"Lancet"},{"key":"10.1006\/gyno.1999.5519_RF21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(89)91141-0","article-title":"Adjuvant tamoxifen in early breast cancer. Occurrence of new primary cancer","volume":"I","author":"Fornander","year":"1989","journal-title":"Lancet"},{"key":"10.1006\/gyno.1999.5519_RF22","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/jnci\/88.21.1529","article-title":"The worth of 5 versus more than 5 years of tamoxifen therapy for breast cancer patients with negative nodes and estrogen receptor positive tumors: an update of NSABP-14","volume":"88","author":"Fisher","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1006\/gyno.1999.5519_RF23","unstructured":"The International Agency for Research on Cancer, Feb. 1996"},{"key":"10.1006\/gyno.1999.5519_RF24","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(05)78975-3","article-title":"Endometrial changes during tamoxifen treatment","volume":"351","author":"Ismail","year":"1998","journal-title":"Lancet"},{"key":"10.1006\/gyno.1999.5519_RF25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0959-8049(97)89314-8","volume":"34S","author":"Montzka","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1006\/gyno.1999.5519_RF26","first-page":"26","article-title":"Relationship between tamoxifen duration and endometrial thickness","volume":"46","author":"Love","year":"1997","journal-title":"Breast Cancer Res Treat"},{"key":"10.1006\/gyno.1999.5519_RF27","first-page":"187","volume":"27S","author":"Fallo","year":"1997","journal-title":"Maturotas"},{"key":"10.1006\/gyno.1999.5519_RF28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/gyno.1997.4739","article-title":"Comparison of endometrial changes among symptomatic tamoxifen-treated and non-treated premenopausal and postmenopausal breast cancer patients","volume":"66","author":"Cheng","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.1999.5519_RF29","first-page":"657","article-title":"Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings","volume":"168","author":"Hann","year":"1997","journal-title":"Am J Radiol"},{"key":"10.1006\/gyno.1999.5519_RF30","first-page":"109A","article-title":"A comparison of endometrial polyps in patients receiving tamoxifen with two control groups","volume":"76","author":"Schlesinger","year":"1997","journal-title":"Lab Invest"},{"key":"10.1006\/gyno.1999.5519_RF31","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1046\/j.1469-0705.1997.08060408.x","article-title":"indices of differential endometrial:myometrial growth may be used to improve the reliability of detecting endometrial neoplasia in women on tamoxifen","volume":"8","author":"Pepper","year":"1996","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1006\/gyno.1999.5519_RF32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00042192-199603040-00029","article-title":"Screening and monitering endometrial response to tamoxifen therapy for breast cancer","volume":"3","author":"Goldstein","year":"1996","journal-title":"Menopause"},{"key":"10.1006\/gyno.1999.5519_RF33","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0002-9378(94)70209-8","article-title":"Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen","volume":"1\/0","author":"Goldstein","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.1999.5519_RF34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0029-7844(97)00591-7","article-title":"Uterine side effects of tamoxifen: a need for systematic pretreatment screening","volume":"91","author":"Berliere","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.1999.5519_RF35","unstructured":"ACOG Committee, Opinion on tamoxifen and endometrial cancer. No. 169, February 1996"},{"key":"10.1006\/gyno.1999.5519_RF36","series-title":"Tamoxifen: a guide for clinicians and patients","article-title":"Endometrial cancer and tamoxifen","author":"Barakat","year":"1996"},{"key":"10.1006\/gyno.1999.5519_RF37","unstructured":"Cummings, S, R, Norton, L, Eckert, S, Grady, D, Cauley, J, Knickerbocker, R, Black, D, M, Nickelson, I, Glusman, J, Krueger, K, and the, MORE investigators, Raloxifene reduces the risk of breast cancer and may decrease the risk of endometrial cancer in post-menopausal women. Two-year findings from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial. Proc Am Soc Clin Oncol, plenary session, 1998, [Abstract 3]"},{"key":"10.1006\/gyno.1999.5519_RF38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(97)24029-8","article-title":"Ambiguous genitalia in infant exposed to tamoxifen in-utero","volume":"350","author":"Tewari","year":"1997","journal-title":"Lancet"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825899955191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825899955191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:18:22Z","timestamp":1758770302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825899955191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,10]]}},"alternative-id":["S0090825899955191"],"URL":"https:\/\/doi.org\/10.1006\/gyno.1999.5519","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[1999,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tamoxifen and Endometrial Pathologies: A Prospective Study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/gyno.1999.5519","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1999 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}